Synvisc-One is a single-dose treatment that is injected directly into your knee by a doctor. To watch a video of a real patient’s injection,click here. Who provides Synvisc-One? Synvisc-One is usually administered by a specialist trained in treating knee osteoarthritis, such as an orthopaedi...
欧洲批准Genzyme公司Synvisc(hylan G-F20)单一用药的Synvisc—One上市解除膝关节炎疼痛.本品可解除膝关节炎的疼痛达6个月,其为目前欧洲惟一适应证为单一注射长期解除疼痛的黏稠填补剂.Genzyme公司认为本品可简化骨关节炎的治疗,方便患者就医,降低医疗总费用. 关键词: 单一治疗;欧洲;Genzyme公司;上市;膝关节炎;医疗总...
2009年2月26日,Crenzyme公司宣布FDA已批准Synvisc- One(hylan G—F20)上市,用于膝骨关节炎(OA)患者以缓解疼痛.相较于目前的隔周注射3次2mL关节腔内注射产品,新配方将这3个剂量合并在6mL注射剂中, 一次性注射可解除膝关节炎的疼痛达6个月,它是唯一在美国获准用于治疗膝部OA疼痛的一次性注射型透明质酸黏弹性补...
Food and Drug Administration's (FDA) approval of Genzyme's Synvisc-One single-injection visco supplement for the treatment of osteoarthritis knee pain. It is the first of its kind approved in the U.S. and is expected to increase the company's current market share of approximately 40%. ...
Synvisc-One (hylan G-F 20) can provide you up to six months of osteoarthritis (OA) knee pain relief with a single injection.
Synvisc-One (hylan G-F 20) can provide you up to six months of osteoarthritis (OA) knee pain relief with a single injection.
Approximately one percent of users experience side effects from Synvisc. Most of these can easily be managed and will fade over time. Common side effects includemild pain, heat, swelling or redness around the injection site. Let your doctor know if these side effects occur to ensure that this...
Get information about the Synvisc‐One® (Hylan G‐F 20) injection. Help your patients relieve osteoarthritis knee pain for up to six months. Sign up to stay informed.
Synvisc comes in two different formulations, SYNVISC(R) and SYNVISC-One(R). SYNVISC-One(R) is a single dose treatment, compared with the three injections required with SYNVISC(R). As with other preparations, it should not be administered to patients with infected joints, with active skin dise...
One hundred ninety knee joints in 187 patients were studied (OA symptoms were bilateral in 3 women). Synvisc(R) was indicated for the local treatment of pain in osteoarthritis of the knee. After the diagnosis, Synvisc(R) therapy was started at the recommended dose of 2 ml per intra-...